BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/30/2024 9:47:16 AM | Browse: 125 | Download: 860
 |
Received |
|
2024-08-15 05:37 |
|
Peer-Review Started |
|
2024-08-19 00:19 |
|
First Decision by Editorial Office Director |
|
2024-09-18 05:46 |
|
Return for Revision |
|
2024-09-18 05:46 |
|
Revised |
|
2024-10-02 04:10 |
|
Publication Fee Transferred |
|
2024-11-25 13:08 |
|
Second Decision by Editor |
|
2024-11-08 10:53 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-11-25 10:31 |
|
Articles in Press |
|
2024-11-25 10:31 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-12-20 02:02 |
|
Publish the Manuscript Online |
|
2024-12-30 09:47 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Basic Study |
| Article Title |
L-arginine administration exacerbates myocardial injury in diabetics via prooxidant and proinflammatory mechanisms along with myocardial structural disruption
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Rasha A Mansouri, Esam M Aboubakr, Huda F Alshaibi and Adel M Ahmed |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| The Deputyship for Research and Innovation, Ministry of Education in Saudi Arabia |
IF2/PSAU/2022/03/23339 |
|
| Corresponding Author |
Esam M Aboubakr, Associate Professor, PhD, Department of Pharmacology and Toxicology, Faculty of Pharmacy-South Valley University, Qena- South valley university, Qena 83523, Egypt. esam_pharma@svu.edu.eg |
| Key Words |
L-arginine administration; Type 2 diabetes; Cardiac muscle injury; Oxidative stress; Inflammatory cytokines; Desmin disruption |
| Core Tip |
L-arginine is commonly used amino acid with many physiological effects, but its safety and pharmacological effects are not fully understood and still controversial. This study found that a dose of 0.5 g/kg of L-arginine appears to be the highest dose that can be safely administered without producing cardiac damage in diabetic rats. However, doses of 1 g/kg or higher can worsen myocardial damage by increasing blood glucose levels, inflammation, and oxidative stress. L-arginine can also reduce body weight and improve lipid levels in rats, but these benefits do not outweigh the injurious effects of high doses on the cardiac muscle. |
| Publish Date |
2024-12-30 09:47 |
| Citation |
Mansouri RA, Aboubakr EM, Alshaibi HF, Ahmed AM. L-arginine administration exacerbates myocardial injury in diabetics via prooxidant and proinflammatory mechanisms along with myocardial structural disruption. World J Diabetes 2025; 16(2): 100395 |
| URL |
https://www.wjgnet.com/1948-9358/full/v16/i2/100395.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v16.i2.100395 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
